Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants-Reference-Cited by-同舟云学术

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

Published:2009-07-06 Issue:2 Volume:45 Page:385-391
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bacigalupo A, ,Lamparelli T,Milone G,Sormani M P,Ciceri F,Peccatori J,Locasciulli A,Majolino I,Di Bartolomeo P,Mazza F,Sacchi N,Pollicheni S,Pinto V

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2009151.pdf

Reference28 articles.

1. Gratwohl A, Brand R, Apperley J, Biezen Av A, Bandini G, Devergie A et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 2002; 100: 3877–3886.

2. Ferrara JL, Reddy P . Pathophysiology of graft-versus-host disease. Semin Hematol 2006; 43: 3–10.

3. Teshima T, Ferrara JL . Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol 2002; 39: 15–22.

4. Antin JH, Chen AR, Couriel DR, Ho VT, Nash RA, Weisdorf D . Novel approaches to the therapy of steroid resistant acute graft versus host disease. Biol Blood Marrow Transplant 2004; 10: 655–668.

5. Van Lint MT, Milone G, Leotta S, Uderzo C, Scime R, Dallorso S et al. Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood 2006; 107: 4177–4181.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effects of tacrolimus blood concentrations early after allogeneic hematopoietic stem cell transplantation;Cytotherapy;2024-05

2. Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study;Bone Marrow Transplantation;2023-12-18

3. Planning GvHD preemptive therapy: risk factors, biomarkers, and prognostic scores;Hematology;2023-12-08

4. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults;Cochrane Database of Systematic Reviews;2023-06-21

5. Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease;Cytotherapy;2022-12